Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 studyMax S. Topp, Hagop M. Kantarjian, Hervé Dombret et al.|The Lancet Oncology|2014Cited by 1.3k
Venetoclax (VEN) Monotherapy for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapsed after or Were Refractory to Ibrutinib or IdelalisibJeffrey A. Jones, Steven Coutré, Michael Y. Choi et al.|Blood|2016Cited by 58
Venetoclax activity in CLL patients who have relapsed after or are refractory to ibrutinib or idelalisib.Jeffrey A. Jones, Steven Coutré, William G. Wierda et al.|Journal of Clinical Oncology|2016Cited by 22